We are analyzing https://link.springer.com/article/10.1007/s10552-013-0332-8.

Title:
A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium | Cancer Causes & Control
Description:
Purpose Breast cancer is a heterogeneous disease, with at least five intrinsic subtypes defined by molecular characteristics. Tumors that express the estrogen receptor (ER+) have better outcomes than ER− tumors, due in part to the success of hormonal therapies that target ER+ tumors. The incidence of ER− breast cancer, and the subset of ER− cancers that are basal-like, is about twice as high among African American (AA) women as among US women of European descent (EA). This disparity appears to explain, in part, the disproportionately high mortality from breast cancer that occurs in AA women. Epidemiologic research on breast cancer in AA women lags behind research in EA women. Here, we review differences in the etiology of breast cancer subtypes among AA women and describe a new consortium of ongoing studies of breast cancer in AA women. Methods We combined samples and data from four large epidemiologic studies of breast cancer in AA women, two cohort and two case-control, creating the African American Breast Cancer Epidemiology and Risk consortium. Tumor tissue is obtained and stored in tissue microarrays, with assays of molecular markers carried out at a pathology core. Genotyping, carried out centrally, includes a whole exome SNP array and over 180,000 custom SNPs for fine-mapping of genome-wide association studies loci and candidate pathways. Results To date, questionnaire data from 5,739 breast cancer cases and 14,273 controls have been harmonized. Genotyping of the first 3,200 cases and 3,700 controls is underway, with a total of 6,000 each expected by the end of the study period. Conclusions The new consortium will likely have sufficient statistical power to assess potential risk factors, both genetic and non-genetic, in relation to specific subtypes of breast cancer in AA women.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,542,331 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

cancer, pubmed, breast, article, google, scholar, cas, women, risk, central, study, epidemiol, african, american, receptor, res, biomarkers, prev, subtypes, status, studies, estrogen, obesity, body, palmer, casecontrol, epidemiology, association, factors, health, activity, research, consortium, white, molecular, differences, loci, hormone, clin, oncol, black, med, physical, vitamin, tumor, africanamerican, progesterone, treat, chen, natl,

Topics {✒️}

gene-environment-wide interaction studies—challenges month download article/chapter hormone-receptor-defined breast cancer multi-institutional case-control study adams-campbell ll her2/neu-overexpressing phenotypes hormone-related risk factors health/national heart lung early-stage breast carcinoma called triple-negative phenotype node-positive breast cancer genome-wide association studies genome-wide association study triple-negative breast cancer ruiz-narvaez ea major racial/ethnic groups integrating population-based epidemiology edward ruiz-narvaez full article pdf ethnicity-related variation national cancer institute postmenopausal african-american women genetic susceptibility loci related subjects triple-negative phenotype amber consortium investigators privacy choices/manage cookies chi-chen hong dose-response meta-analysis insulin-resistance syndrome hormone receptor status breast cancer defined camargo ca jr progesterone receptor status negative breast biopsy cheang mc breast cancer based central obesity innate immunity pathways bandera ev article cancer anderson wf estrogen-receptor status estrogen receptor status breast cancer subtypes breast cancer emerging breast cancer survivors situ breast cancer preventing breast cancer cytokine gene polymorphisms

Schema {🗺️}

WebPage:
      mainEntity:
         headline:A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium
         description:Breast cancer is a heterogeneous disease, with at least five intrinsic subtypes defined by molecular characteristics. Tumors that express the estrogen receptor (ER+) have better outcomes than ER− tumors, due in part to the success of hormonal therapies that target ER+ tumors. The incidence of ER− breast cancer, and the subset of ER− cancers that are basal-like, is about twice as high among African American (AA) women as among US women of European descent (EA). This disparity appears to explain, in part, the disproportionately high mortality from breast cancer that occurs in AA women. Epidemiologic research on breast cancer in AA women lags behind research in EA women. Here, we review differences in the etiology of breast cancer subtypes among AA women and describe a new consortium of ongoing studies of breast cancer in AA women. We combined samples and data from four large epidemiologic studies of breast cancer in AA women, two cohort and two case-control, creating the African American Breast Cancer Epidemiology and Risk consortium. Tumor tissue is obtained and stored in tissue microarrays, with assays of molecular markers carried out at a pathology core. Genotyping, carried out centrally, includes a whole exome SNP array and over 180,000 custom SNPs for fine-mapping of genome-wide association studies loci and candidate pathways. To date, questionnaire data from 5,739 breast cancer cases and 14,273 controls have been harmonized. Genotyping of the first 3,200 cases and 3,700 controls is underway, with a total of 6,000 each expected by the end of the study period. The new consortium will likely have sufficient statistical power to assess potential risk factors, both genetic and non-genetic, in relation to specific subtypes of breast cancer in AA women.
         datePublished:2013-12-17T00:00:00Z
         dateModified:2013-12-17T00:00:00Z
         pageStart:309
         pageEnd:319
         sameAs:https://doi.org/10.1007/s10552-013-0332-8
         keywords:
            Breast cancer
            Molecular subtypes
            Epidemiology
            African American
            Cancer Research
            Biomedicine
            general
            Oncology
            Public Health
            Hematology
         image:
         isPartOf:
            name:Cancer Causes & Control
            issn:
               1573-7225
               0957-5243
            volumeNumber:25
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Julie R. Palmer
               affiliation:
                     name:Slone Epidemiology Center at Boston University
                     address:
                        name:Slone Epidemiology Center at Boston University, Boston, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Christine B. Ambrosone
               affiliation:
                     name:Roswell Park Cancer Institute
                     address:
                        name:Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Andrew F. Olshan
               affiliation:
                     name:University of North Carolina Chapel Hill
                     address:
                        name:Department of Epidemiology and Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium
      description:Breast cancer is a heterogeneous disease, with at least five intrinsic subtypes defined by molecular characteristics. Tumors that express the estrogen receptor (ER+) have better outcomes than ER− tumors, due in part to the success of hormonal therapies that target ER+ tumors. The incidence of ER− breast cancer, and the subset of ER− cancers that are basal-like, is about twice as high among African American (AA) women as among US women of European descent (EA). This disparity appears to explain, in part, the disproportionately high mortality from breast cancer that occurs in AA women. Epidemiologic research on breast cancer in AA women lags behind research in EA women. Here, we review differences in the etiology of breast cancer subtypes among AA women and describe a new consortium of ongoing studies of breast cancer in AA women. We combined samples and data from four large epidemiologic studies of breast cancer in AA women, two cohort and two case-control, creating the African American Breast Cancer Epidemiology and Risk consortium. Tumor tissue is obtained and stored in tissue microarrays, with assays of molecular markers carried out at a pathology core. Genotyping, carried out centrally, includes a whole exome SNP array and over 180,000 custom SNPs for fine-mapping of genome-wide association studies loci and candidate pathways. To date, questionnaire data from 5,739 breast cancer cases and 14,273 controls have been harmonized. Genotyping of the first 3,200 cases and 3,700 controls is underway, with a total of 6,000 each expected by the end of the study period. The new consortium will likely have sufficient statistical power to assess potential risk factors, both genetic and non-genetic, in relation to specific subtypes of breast cancer in AA women.
      datePublished:2013-12-17T00:00:00Z
      dateModified:2013-12-17T00:00:00Z
      pageStart:309
      pageEnd:319
      sameAs:https://doi.org/10.1007/s10552-013-0332-8
      keywords:
         Breast cancer
         Molecular subtypes
         Epidemiology
         African American
         Cancer Research
         Biomedicine
         general
         Oncology
         Public Health
         Hematology
      image:
      isPartOf:
         name:Cancer Causes & Control
         issn:
            1573-7225
            0957-5243
         volumeNumber:25
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Julie R. Palmer
            affiliation:
                  name:Slone Epidemiology Center at Boston University
                  address:
                     name:Slone Epidemiology Center at Boston University, Boston, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Christine B. Ambrosone
            affiliation:
                  name:Roswell Park Cancer Institute
                  address:
                     name:Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Andrew F. Olshan
            affiliation:
                  name:University of North Carolina Chapel Hill
                  address:
                     name:Department of Epidemiology and Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Causes & Control
      issn:
         1573-7225
         0957-5243
      volumeNumber:25
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Slone Epidemiology Center at Boston University
      address:
         name:Slone Epidemiology Center at Boston University, Boston, USA
         type:PostalAddress
      name:Roswell Park Cancer Institute
      address:
         name:Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, USA
         type:PostalAddress
      name:University of North Carolina Chapel Hill
      address:
         name:Department of Epidemiology and Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, Chapel Hill, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Julie R. Palmer
      affiliation:
            name:Slone Epidemiology Center at Boston University
            address:
               name:Slone Epidemiology Center at Boston University, Boston, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Christine B. Ambrosone
      affiliation:
            name:Roswell Park Cancer Institute
            address:
               name:Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, USA
               type:PostalAddress
            type:Organization
      name:Andrew F. Olshan
      affiliation:
            name:University of North Carolina Chapel Hill
            address:
               name:Department of Epidemiology and Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, Chapel Hill, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Slone Epidemiology Center at Boston University, Boston, USA
      name:Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, USA
      name:Department of Epidemiology and Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, Chapel Hill, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(363)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.81s.

LINK . SPRINGER . COM {}